Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1977 1
1978 2
1979 1
1981 1
1982 4
1983 2
1984 1
1985 1
1986 1
1987 1
1989 1
1991 1
1992 2
1993 2
1994 4
1995 4
1996 2
1997 4
1998 3
1999 2
2000 4
2001 3
2002 2
2004 1
2005 2
2006 2
2007 4
2008 3
2009 1
2010 2
2011 2
2012 6
2013 5
2014 8
2015 8
2016 11
2017 7
2018 1
2019 8
2020 7
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Results by year
Filters applied: . Clear all
Page 1
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP; Secukinumab in Crohn's Disease Study Group. Hueber W, et al. Among authors: bruin g. Gut. 2012 Dec;61(12):1693-700. doi: 10.1136/gutjnl-2011-301668. Epub 2012 May 17. Gut. 2012. PMID: 22595313 Free PMC article. Clinical Trial.
Rasch Analysis of the Proactive Personality Scale.
Teye-Kwadjo E, de Bruin GP. Teye-Kwadjo E, et al. Among authors: de bruin gp. Psychol Rep. 2021 Jun 29:332941211028110. doi: 10.1177/00332941211028110. Online ahead of print. Psychol Rep. 2021. PMID: 34187235
Discovery of quinoline-based irreversible BTK inhibitors.
de Bruin G, Demont D, de Zwart E, Verkaik S, Hoogenboom N, van de Kar B, van Lith B, Emmelot-van Hoek M, Gulrajani M, Covey T, Kaptein A, Barf T. de Bruin G, et al. Bioorg Med Chem Lett. 2020 Jul 15;30(14):127261. doi: 10.1016/j.bmcl.2020.127261. Epub 2020 May 13. Bioorg Med Chem Lett. 2020. PMID: 32527559
Integrated chip-based capillary electrophoresis.
Effenhauser CS, Bruin GJ, Paulus A. Effenhauser CS, et al. Among authors: bruin gj. Electrophoresis. 1997 Nov;18(12-13):2203-13. doi: 10.1002/elps.1150181211. Electrophoresis. 1997. PMID: 9456035 Review.
Reply.
Buckley N, Bruin G. Buckley N, et al. Among authors: bruin g. Can J Anaesth. 1998 Jan;45(1):93. doi: 10.1007/BF03012004. Can J Anaesth. 1998. PMID: 27519040 No abstract available.
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Kolbinger F, Di Padova F, Deodhar A, Hawkes JE, Huppertz C, Kuiper T, McInnes IB, Ritchlin CT, Rosmarin D, Schett G, Carballido JM, Häusermann P, Calonder C, Vogel B, Rondeau JM, Bruin G. Kolbinger F, et al. Among authors: bruin g. Pharmacol Ther. 2022 Jan;229:107925. doi: 10.1016/j.pharmthera.2021.107925. Epub 2021 Jun 23. Pharmacol Ther. 2022. PMID: 34171337 Free article. Review.
Proteasome inhibitors with photocontrolled activity.
Hansen MJ, Velema WA, de Bruin G, Overkleeft HS, Szymanski W, Feringa BL. Hansen MJ, et al. Among authors: de bruin g. Chembiochem. 2014 Sep 22;15(14):2053-7. doi: 10.1002/cbic.201402237. Epub 2014 Aug 14. Chembiochem. 2014. PMID: 25125335
123 results